Whan In PharmLtd (A016580) Stock Overview
Manufactures and sells various pharmaceutical products in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
A016580 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Looking to be second time lucky with a game-changing new product
Key Takeaways Unicycive has successfully completed clinical development of its lead asset, Oxylanthanum Carbonate (OLC). OLC has been designed to improve on current phosphate binders by offering better efficacy, fewer pills, and improved tolerability over alternative treatments for hyperphosphatemia chronic kidney disease patients on dialysis.Read more
Whan In Pharm Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩10,760.00 |
| 52 Week High | ₩13,210.00 |
| 52 Week Low | ₩10,050.00 |
| Beta | 0.13 |
| 1 Month Change | 2.18% |
| 3 Month Change | -6.43% |
| 1 Year Change | -6.52% |
| 3 Year Change | -37.62% |
| 5 Year Change | -43.07% |
| Change since IPO | -9.58% |
Recent News & Updates
Recent updates
Did Whan In Pharm Co.,Ltd. (KRX:016580) Use Debt To Deliver Its ROE Of 7.8%?
Mar 15
Here's Why I Think Whan In PharmLtd (KRX:016580) Might Deserve Your Attention Today
Feb 25Whan In Pharm Co.,Ltd.'s (KRX:016580) 1.6% Dividend Yield Looks Pretty Interesting
Feb 04
What Is The Ownership Structure Like For Whan In Pharm Co.,Ltd. (KRX:016580)?
Jan 14Why You Might Be Interested In Whan In Pharm Co.,Ltd. (KRX:016580) For Its Upcoming Dividend
Dec 24Does Whan In Pharm Co.,Ltd. (KRX:016580) Create Value For Shareholders?
Dec 11Whan In PharmLtd's (KRX:016580) Shareholders Are Down 33% On Their Shares
Nov 20Shareholder Returns
| A016580 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 0.7% | 0.3% | 3.4% |
| 1Y | -6.5% | 46.1% | 100.6% |
Return vs Industry: A016580 underperformed the KR Pharmaceuticals industry which returned 46.1% over the past year.
Return vs Market: A016580 underperformed the KR Market which returned 100.6% over the past year.
Price Volatility
| A016580 volatility | |
|---|---|
| A016580 Average Weekly Movement | 2.4% |
| Pharmaceuticals Industry Average Movement | 5.1% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in KR Market | 13.1% |
| 10% least volatile stocks in KR Market | 2.9% |
Stable Share Price: A016580 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A016580's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | 601 | Wonbum Lee | www.whanin.com |
Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products, such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, antiseizure, antidepressant, antipsychotic, central nervous system stimulant, anti-dementia, nootropic, alcohol use disorder, anti-Parkinson, multivitamin, external preparation, medical device, and sedative, hypnotic, and autonomic nervous system medications.
Whan In Pharm Co.,Ltd. Fundamentals Summary
| A016580 fundamental statistics | |
|---|---|
| Market cap | ₩164.27b |
| Earnings (TTM) | ₩15.17b |
| Revenue (TTM) | ₩256.32b |
Is A016580 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A016580 income statement (TTM) | |
|---|---|
| Revenue | ₩256.32b |
| Cost of Revenue | ₩172.26b |
| Gross Profit | ₩84.07b |
| Other Expenses | ₩68.90b |
| Earnings | ₩15.17b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 993.49 |
| Gross Margin | 32.80% |
| Net Profit Margin | 5.92% |
| Debt/Equity Ratio | 0% |
How did A016580 perform over the long term?
See historical performance and comparisonDividends
Does A016580 pay a reliable dividends?
See A016580 dividend history and benchmarks| Whan In PharmLtd dividend dates | |
|---|---|
| Ex Dividend Date | Dec 29 2025 |
| Dividend Pay Date | Apr 16 2026 |
| Days until Ex dividend | 52 days |
| Days until Dividend pay date | 56 days |
Does A016580 pay a reliable dividends?
See A016580 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/18 21:50 |
| End of Day Share Price | 2026/02/13 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Whan In Pharm Co.,Ltd. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Seung-Ho Lee | iM Securities |
| Hong-Sik Jeong | LS Securities Co., Ltd. |
| Woo-sung Jung | LS Securities Co., Ltd. |